Sweden
· Delayed Price · Currency is SEK Abera Bioscience AB Statistics
Total Valuation
NGM:ABERA has a market cap or net worth of SEK 90.58 million. The enterprise value is 84.49 million.
| Market Cap | 90.58M |
| Enterprise Value | 84.49M |
Important Dates
The last earnings date was Friday, February 7, 2025.
| Earnings Date | Feb 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NGM:ABERA has 15.35 million shares outstanding. The number of shares has increased by 15.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 15.35M |
| Shares Change (YoY) | +15.71% |
| Shares Change (QoQ) | +10.45% |
| Owned by Insiders (%) | 6.04% |
| Owned by Institutions (%) | n/a |
| Float | 14.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.10 |
| PB Ratio | 10.46 |
| P/TBV Ratio | 10.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -76.81 |
| EV / Sales | 5.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -63.57 |
Financial Position
The company has a current ratio of 2.15
| Current Ratio | 2.15 |
| Quick Ratio | 1.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,120.00 |
Financial Efficiency
Return on equity (ROE) is -15.37% and return on invested capital (ROIC) is -9.78%.
| Return on Equity (ROE) | -15.37% |
| Return on Assets (ROA) | -6.10% |
| Return on Invested Capital (ROIC) | -9.78% |
| Return on Capital Employed (ROCE) | -12.94% |
| Revenue Per Employee | 2.47M |
| Profits Per Employee | -183,333 |
| Employee Count | 6 |
| Asset Turnover | 1.29 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.17% in the last 52 weeks. The beta is 0.89, so NGM:ABERA's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +12.17% |
| 50-Day Moving Average | 4.58 |
| 200-Day Moving Average | 4.36 |
| Relative Strength Index (RSI) | 68.21 |
| Average Volume (20 Days) | 13,676 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NGM:ABERA had revenue of SEK 14.85 million and -1.10 million in losses. Loss per share was -0.07.
| Revenue | 14.85M |
| Gross Profit | 14.85M |
| Operating Income | -1.12M |
| Pretax Income | -1.10M |
| Net Income | -1.10M |
| EBITDA | -1.06M |
| EBIT | -1.12M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 6.09 million in cash and n/a in debt, giving a net cash position of 6.09 million or 0.40 per share.
| Cash & Cash Equivalents | 6.09M |
| Total Debt | n/a |
| Net Cash | 6.09M |
| Net Cash Per Share | 0.40 |
| Equity (Book Value) | 8.66M |
| Book Value Per Share | 0.56 |
| Working Capital | 5.70M |
Cash Flow
In the last 12 months, operating cash flow was -198,000 and capital expenditures -1.13 million, giving a free cash flow of -1.33 million.
| Operating Cash Flow | -198,000 |
| Capital Expenditures | -1.13M |
| Free Cash Flow | -1.33M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 100.00%, with operating and profit margins of -7.54% and -7.41%.
| Gross Margin | 100.00% |
| Operating Margin | -7.54% |
| Pretax Margin | -7.41% |
| Profit Margin | -7.41% |
| EBITDA Margin | -7.13% |
| EBIT Margin | -7.54% |
| FCF Margin | n/a |
Dividends & Yields
NGM:ABERA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.71% |
| Shareholder Yield | -15.71% |
| Earnings Yield | -1.21% |
| FCF Yield | -1.47% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |